DDR1 and pancreatic adenocarcinoma: DDR1 expression shows a significant negative correlation with multiple major histocompatibility complex (MHC) class II genes, especially in LUSC and PAAD, as depicted in Figure 6C, which implies that DDR1 may impair antigen presentation [29].